Farzan, F., Dadbinpour, A., Ekraminasab, S., Fallahzadeh, H., Mazaheri, M. (2022). Positive Predictive Value of Screening Tests in the First and Second Trimester of Pregnancy in the Diagnosis of Trisomy 21, 18, and 13 Using Amniocentesis. Shahid Sadoughi University of Medical Sciences- Journal Management System, 5(2), 74-82. doi: 10.18502/wjpn.v5i2.11994
Fatemeh Farzan; Ali Dadbinpour; Sedigheh Ekraminasab; Hossein Fallahzadeh; Mahta Mazaheri. "Positive Predictive Value of Screening Tests in the First and Second Trimester of Pregnancy in the Diagnosis of Trisomy 21, 18, and 13 Using Amniocentesis". Shahid Sadoughi University of Medical Sciences- Journal Management System, 5, 2, 2022, 74-82. doi: 10.18502/wjpn.v5i2.11994
Farzan, F., Dadbinpour, A., Ekraminasab, S., Fallahzadeh, H., Mazaheri, M. (2022). 'Positive Predictive Value of Screening Tests in the First and Second Trimester of Pregnancy in the Diagnosis of Trisomy 21, 18, and 13 Using Amniocentesis', Shahid Sadoughi University of Medical Sciences- Journal Management System, 5(2), pp. 74-82. doi: 10.18502/wjpn.v5i2.11994
Farzan, F., Dadbinpour, A., Ekraminasab, S., Fallahzadeh, H., Mazaheri, M. Positive Predictive Value of Screening Tests in the First and Second Trimester of Pregnancy in the Diagnosis of Trisomy 21, 18, and 13 Using Amniocentesis. Shahid Sadoughi University of Medical Sciences- Journal Management System, 2022; 5(2): 74-82. doi: 10.18502/wjpn.v5i2.11994
Positive Predictive Value of Screening Tests in the First and Second Trimester of Pregnancy in the Diagnosis of Trisomy 21, 18, and 13 Using Amniocentesis
1The Ali-ibne-Abitaleb School of Medicine, Islamic. Azad University of Yazd, Yazd, Iran
2Genetic and Environmental Adventures Research Center, School of Abarkouh paramedicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
3Department of Medical Genetics, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
4Mother and Newborn Health Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
5Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
6Research Center of Prevention and Epidemiology of Non-Communicable Disease, Department of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
7Stem Cell Biology Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Abstract
Background: The aim of this study is to analyze the positive predictive value (PPV) of trisomies 21, 18 and 13 at first and second trimester using amniocentesis for clinical practice. Methods: : This is a descriptive cross-sectional study in which data were extracted from a cohort project of mother and infant conducted between March 2016 and February 2021 among 3110 pregnant women in Yazd city. Results: Out of 3110 pregnant women, 84 mothers were at high risk in the screening tests of the first and second trimesters of pregnancy and therefore were candidates for amniocentesis. None of them were detected by the positive amniocentesis method. The mean age of mothers was 33.2 years. The causes of amniocentesis included old age (45.9%), positive results of Down syndrome screening (23%), high NT ultrasound (4.9%), and pathological results of anomaly scan sonography (3.8%). Conclusion: In this study, the PPV was zero and the number of false positives in screening tests was 84 (100%). This may be because our population was normal and had no history of genetic abnormalities or other special conditions.
Chen Y, Wang X, Li L, Lu S, Zhang Z. New cut-off values for screening of trisomy 21, 18 and open neural tube defects (ONTD) during the second trimester in pregnant women with advanced maternal age. BMC Pregnancy Childbirth 2020; 20(1): 776.
Lan RY, Chou CT, Wang PH, Chen RC, Hsiao CH. Trisomy 21 screening based on first and second trimester in a Taiwanese population. Taiwan J Obstet Gynecol 2018; 57(4): 551-4.
Li SW, Barrett AN, Gole L, Tan WC, Biswas A, Tan HK, et al. The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort. Singapore Med J 2015; 56(1): 47-52.
Güdücü N, Görmüş U, Güner Eİ, Güzel Ö, Kavak ZN. Quadruple test parameters in art pregnancies. Int J Clin Exp Med 2014; 7(8): 2319-23.
Boonpiam R, Wanapirak C, Sirichotiyakul S, Sekararithi R, Traisrisilp K, Tongsong T. Quad test for fetal aneuploidy screening as a predictor of small-for-gestational age fetuses: a population-based study. BMC Pregnancy Childbirth 2020; 20(1): 621.
Shaw SWS, Lin SY, Lin CH, Su YN, Cheng PJ, Lee CN, et al. Second-trimester maternal serum quadruple test for down syndrome screening: A Taiwanese population-based study. Taiwan J Obstet Gynecol 2010; 49(1): 30-4.
Sharda S, Phadke SR. Uptake of invasive prenatal diagnostic tests in women after detection of soft markers for chromosomal abnormality on ultrasonographic evaluation. J Perinatol 2007; 27(9): 550-5.
Siljee JE, Knegt AC, Knapen MFCM, Bekker MN, Visser GHA, Schielen PCJI. Positive predictive values for detection of trisomies 21, 18 and 13 and termination of pregnancy rates after referral for advanced maternal age, first trimester combined test or ultrasound abnormalities in a national screening programme (2007-2009). Prenat Diagn 2014; 34(3): 259-64.
Neufeld-Kaiser WA, Cheng EY, Liu YJ. Positive predictive value of non-invasive prenatal screening for fetal chromosome disorders using cell-free DNA in maternal serum: Independent clinical experience of a tertiary referral center. BMC Med 2015; 13(1): 129.
Ali Akbari N, Tooba K. Analyzing indications of amniocentesis and positive predictive value (PPV) of cytogenetic findings of chromosomal abnormalities. Rev Latinoam Hipertens 2019; 14(3): 313-9.
Zhu H, Jin X, Xu Y, Zhang W, Liu X, Jin J, et al. Efficiency of non-invasive prenatal screening in pregnant women at advanced maternal age. BMC Pregnancy Childbirth 2021; 21(6): 86.
Petersen AK, Cheung SW, Smith JL, Bi W, Ward PA, Peacock S, et al. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory. Am J Obstet Gynecol 2017; 217(6): 691.e1-691.e6.
Shirazi M, Sarmadi S, Niromanesh S, Rahimi Sharbaf F, Sahebdel B, Golshahi F, et al. Assessment of the sensitivity and specificity of screening tests performed in the first and second trimester in the pregnant women. J Obstet Gynecol Cancer Res 2019; 4(1): 12-5.
Yassaee F, Shekarriz-Foumani R, Sadeghi S. Amniocentesis following positive first trimester combined screening: A comparative study. Acta Med Iran 2019; 57(6): 359-62.
Heidari R, Akbariqomi M, Motevaseli E, Omrani MD, Kooshki H, Shamshiri AR, et al. Performance and predictive value of first trimester screening markers for down syndrome in Iranian pregnancies. J Family Reprod Health 2018; 12(3): 121-8.
Abib LPA, De Sá RAM, Peixoto-Filho FM. First-trimester combined screening test for aneuploidies in Brazilian unselected pregnancies: Diagnostic performance of fetal medicine foundation algorithm. Rev Bras Ginecol Obstet 2018; 40(7): 384-9.
Dar P, Gross SJ, Benn P. Positive predictive values and false-positive results in noninvasive prenatal screening. Am J Obstet Gynecol 2015; 213(4): 595-6.
Meck JM, Dugan EK, Matyakhina L, Aviram A, Trunca C, Pineda-Alvarez D, et al. Noninvasive prenatal screening for aneuploidy: Positive predictive values based on cytogenetic findings. Am J Obstet Gynecol 2015; 213(2): 214.e1-5.
